TYRP1 directed CAR T cells control tumor progression in preclinical melanoma models is a research paper published in Molecular Therapy Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCATS NIH HHS
Grant: UL1 TR002384
NCI NIH HHS
Grant: U01 CA256801
NCI NIH HHS
Grant: UE5 CA246754
NCI NIH HHS
Grant: R01 CA262516
NCI NIH HHS
Grant: K12 CA184746
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: P50 CA217694
NCI NIH HHS
Grant: R01 CA249294
NCI NIH HHS
Grant: R01 CA286507
NCI NIH HHS
Grant: P50 CA211024
NCI NIH HHS
Grant: U10 CA180820
NCI NIH HHS
Grant: U01 CA271407
National Institutes of Health
Grant: 5K12CA184746-02
MSK Paul Calabresi Career Development Award for Clinical Oncology
National Institutes of Health
Grant: 5R01CA286507-03
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
National Institutes of Health
Grant: 5U01CA256801-04
Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell LungCancer
National Institutes of Health
Grant: 1P50CA211024-01A1
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
National Institutes of Health
Grant: 5U01CA271407-04
Proteogenomic studies to understand mechanisms and drivers of resistance to immunotherapies
National Institutes of Health
Grant: 5R01CA262516-02
Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity
National Institutes of Health
Grant: 5P50CA217694-04
SPORE in Soft Tissue Sarcoma
National Institutes of Health
Grant: 5UE5CA246754-02
MSK Immuno-Oncology for the Translational Researcher Short Course
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5R01CA249294-05
Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy
National Institutes of Health
Grant: 3U10CA180820-02S3
ECOG-ACRIN Operations Center
US Department of Defense
Parker Institute for Cancer Immunotherapy
Stand Up To Cancer
Breast Cancer Research Foundation
National Institutes of Health
Swim Across America
Melanoma Research Alliance
Ludwig Institute for Cancer Research
FWCI
1.58
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals